Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | ABBVAbbVie Inc. | GILDGilead Sciences, Inc. |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | United States |
| Market cap | $519B | $212B |
| Price | $293.89 | $170.87 |
| Last day | +0.20% | +0.92% |
, a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV analysis and Q-Scores →, a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients.
GILD analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.